ZeptoMetrix® is the industry leader for innovative solutions to challenges in the evolving Infectious Disease Diagnostics market. Our reputation for product quality, reliability, and trusted technical knowledge provides assurance that enables our industry to develop and advance diagnostics technologies. From assay conception to launch, our scientific and operational teams provide our customers with comprehensive, performance-oriented and cost-effective products and services that positively impact the field of clinical diagnostics and its contribution to global healthcare.
ZeptoMetrix offers a variety of customized services employing expertise in virology, bacteriology, molecular biology, immunology, and related disciplines involved with assay development and infectious disease diagnostics applications.
With an extensive collection of microorganisms and expertise in sourcing and propagation of strains of interest, we excel at collaborations with research and product development scientists to discover solutions to challenges unmet by general off-the-shelf product options.
ZeptoMetrix® to release new Non-Infectious Gastrointestinal Verification Panel NATGIP-QIA
FDA suggests ZeptoMetrix® test materials for SARS-CoV-2 assay validation.
ZeptoMetrix® New SARS-CoV-2 Positive Control-NATSARS(COV2)-ERC and accompanying Negative Control- NATSARS(COV2)-NEG are now available.
At ZeptoMetrix, we deeply value our extensive network of partners and collaborators from academic and government consortia to multinational diagnostic systems providers. As a deeply technical service-oriented business, the ability to manage projects and achieve the desired attributes of products under development is guided by a pervasive sense of customer-centricity.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
Choose your country from the regions available below to view the products that are available for purchase at your location
.jpg)